Intra-IMMUSG Pte Ltd
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD) (NCT07547228) | Intra-IMMUSG Pte Ltd | 2025-10-11 |
| Phase II/III Trial of PRL3-Zumab in Advanced Solid Tumor Patients (NCT07290088) | Intra-IMMUSG Pte Ltd | 2023-01-09 |
| PRL3-Zumab in Patients With Advanced Solid Tumors (NCT07541001) | Intra-IMMUSG Pte Ltd | 2021-08-30 |
| A Study to Assess Safety and Efficacy of PRL3-Zumab in Patients With Solid Tumors (NCT04452955) | Intra-IMMUSG Pte Ltd | 2020-12-12 |
Track Intra-IMMUSG Pte Ltd automatically
Every clearance here is in the API, with alerts when new ones post.